Covid's Delta variant dents Vietnam’s economic growth
Southeast Asia is suffering from its worst wave of Covid infections since the pandemic began. And with just 3% of its population vaccinated, Vietnam's economy is in the firing line.

For much of the pandemic, “the globe marvelled” at Vietnam’s “incredibly low Covid-19 infection numbers and negligible death rate”, says William Pesek in Nikkei Asia. Yet governments across Southeast Asia became complacent, assuming that “large-scale vaccination… could wait”. Now, thanks to the Delta strain of Covid-19, the region is suffering from its worst wave of the disease since the pandemic began. Less than 3% of Vietnam’s population is fully vaccinated; much of the country has been placed in lockdown.
Stocks stay buoyant
Still, Hanoi has raised its “vaccination ambitions”. The health ministry aims to get 50% of adults jabbed by the end of the year and 70% by the end of March 2022. Investors have a “half-glass-full view”. Bill Stoops of Dragon Capital Group thinks stocks could rise by 10% as vaccination gets going. The benchmark VN index has gained more than 20% since 1 January, but is down by 6% since early July as Delta has taken hold.
Southeast Asia’s Delta woes are putting new stress on global supply chains, say Jon Emont and Lam Le in The Wall Street Journal. “A gap has formed” between surging goods demand in vaccinated countries and “the capacity of sparsely vaccinated manufacturing countries to meet it”. Closed factories and ports have left multinationals in the “lurch”. Adidas, which sources 28% of its apparel from the country, says most of its Vietnamese suppliers’ factory capacity has been unavailable since mid-July”. That could mean $600m in lost sales during the second half of the year.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
There are also growing concerns about coffee supplies. Vietnam is a leading producer of robusta beans, the variety used in instant coffee. A lockdown in the southern city of Ho Chi Minh is delaying shipments. Global coffee prices had already spiked following drought and frosts in Brazil. Strict movement controls mean that GDP now looks likely to grow by 5% this year, down from a previous forecast of 6.7%, says Chua Han Teng of DBS Bank. It’s not just manufacturers that are hurting. In many places “non-essential businesses and restaurants” have been closed, which is also weighing on the domestic service sector. Still, Vietnam is an outperformer: Vietnam’s economy actually grew last year. That should continue. “Growing interest in Vietnam as a production base” is driving strong foreign investment. The economy is “increasingly integrated into the global electronics value chain”.
Profits at Vietnamese firms are set to grow by 11% in 2021, says Mary McDougall in Investors’ Chronicle. That compares with 7% for Asia ex-Japan as a whole. A “young, enterprising and large workforce” should mean that it remains one of the world’s fastest growing economies. “For patient investors, Vietnam has great fundamentals.”
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
More retirees are buying inflation-protected annuities. What are they and how do they work?
Sales of annuities where the income on offer increases every year have surged – and more people are also taking up enhanced rates that are higher due to illness
-
Was Margaret Thatcher great for Britain?
The 'Iron Lady’ would be celebrating her 100th birthday this month. Margaret Thatcher rose to power in 1979 as the first ever female prime minister and was one of the most controversial leaders in history, but how did her policies shape today’s finances?
-
Pierre-Édouard Stérin wants to make France great again
Conservative billionaire Pierre-Édouard Stérin is seeking to lead a political and spiritual renaissance across the Channel. The planning looks meticulous
-
Global investors have overlooked the top innovators in emerging markets
Opinion Carlos Hardenberg, portfolio manager, Mobius Investment Trust, highlights three emerging market stocks where he’d put his money
-
Pinewood Technologies: a drive for growth
Pinewood Technologies’ platform is one of the best in the business. Investors should buy in
-
'EV maker Faraday Future will crash'
Faraday Future Intelligent Electric is failing dismally to live up to its name, says Matthew Partridge
-
Investors should cheer the coming nuclear summer
The US and UK have agreed a groundbreaking deal on nuclear power, and the sector is seeing a surge in interest from around the world. Here's how you can profit
-
8 of the best houses for sale with follies
The best houses for sale with follies in the grounds – from a five-storey Victorian Gothic tower in Tonbridge, Kent, to a former mill in Oxfordshire with gardens that include a folly on an island in a lake
-
A tale of two Reits – why performance matters for valuation
AEW UK and Regional are two Reits that are valued very differently, despite a shared focus on properties outside London
-
Healthcare stocks look cheap, but tread carefully
Shares in healthcare companies could get a shot in the arm if uncertainty over policy in the US wanes, but are they worth the risk?